查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球肾脏功能测试市场 - 2023-2030年
市场调查报告书
商品编码
1297823

全球肾脏功能测试市场 - 2023-2030年

Global Kidney Function Tests Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球肾功能测试市场在2022年达到了9亿美元，预计到2030年将见证有利可图的增长，达到14亿美元。在2023-2030年的预测期内，该市场预计将呈现6.3%的复合增长率。

肾功能测试可以识别肾脏或肾功能紊乱，并协助医生开出适当的药物。稀释试验、清除试验和其他类型的肾功能测试都可以使用。肾脏疾病，如因体液过多导致的排尿困难、手或脚水肿、脸部肿胀等，都可以通过肾功能测试来确定。

推动市场增长的因素包括美国食品和药物管理局的批准和主要参与者推出的肾功能测试的新产品。例如，2022年7月12日，将智能手机摄像头集成到医疗设备中的全球先驱Healthy.io宣布，Minuteful肾脏测试已获得美国食品和药物管理局（FDA）的510（k）许可，可用于家庭使用。

市场动态

肾脏疾病发病率的增加将推动肾脏功能测试市场的增长

全球慢性肾脏病发病率和流行率的上升是推动全球肾功能检测市场增长的主要因素。例如，根据2021年NIDDK的数据，在美国，每七个成年人中就有一个以上患有慢性肾脏病（CKD），估计总共有3700万人。

患有糖尿病或高血压的美国人患CKD的风险甚至更高，这是肾脏疾病的两个最常见原因。肾脏疾病影响了近三分之一的糖尿病患者和五分之一的高血压患者。

此外，根据美国疾病控制和预防中心（CDC）的《2021年美国慢性肾脏病》，CKD在女性（14%）中的发病率略高于男性（12%），在非西班牙裔黑人成年人中（16%）比非西班牙裔白人成年人（13%）或非西班牙裔亚洲人（13%）更常见。因此，CKD的频率将推动市场扩张。

诊断过程的高成本预计将阻碍市场的增长

肾功能测试的高成本，以及新兴国家和发展中国家的低接受率，将扼杀市场扩张。由于修改公式，临床诊断为肾脏疾病的人数增加，意味着更多的人可能会收到调整剂量的建议，或对某些可能干扰肾脏功能或肾脏过滤不良的药物的禁忌症。

COVID-19影响分析

COVID-19的大流行对医疗系统和市场产生了适度的影响。根据2020年4月发表在medRXiv上的一项研究，在患有各种传染病和有害疾病的人中经常观察到COVID-19尿失禁。已发现0至12岁的儿童有小光型COVID-19的尿路COVID-19暴露。

COVID-19尿路感染是在疾病发生后的第一至第五天之间发现的。肾功能标志物用于确定肾脏的功能如何。有些信号是放射性的，也有非放射性的。它们显示了肾脏的肾小球滤过率以及浓缩和稀释能力（肾小管功能）。许多人宁愿在商店购买肾功能测试，也不愿在网上购买。

俄乌战争影响分析

俄罗斯-乌克兰估计对全球肾功能检测市场的影响很小，因为这个地区的流行率很低，而且没有关键的市场参与者。然而，原材料、测试产品和设备的进出口的影响，预计在预测期内对全球肾功能测试市场的影响不大。

人工智能影响分析

人工智能预计将对全球子痫前期市场产生积极的影响。由人工智能驱动的决策支持系统可以帮助医护人员对肾脏诊断和治疗方案做出明智的判断。这些系统能够分析病人数据，将其与当前的医学知识进行比较，并根据循证指南提出建议。这有助于医生为特定患者选择最佳的诊断测试、药物或行动。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按产品类型分析
  • 按测试类型分析
  • 按终端用户分类
  • 按地区分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 肾功能测试产品的推出越来越多
      • 肾脏疾病的发病率不断上升
    • 限制因素
      • 诊断过程的高成本增长
    • 机会
      • 肾功能测试帮助医疗机构为患者制定个性化的治疗方案
    • 影响分析

第五章：行业分析

  • 波特五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析

第六章：COVID-19分析

  • 对COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第7章 ：俄罗斯-乌克兰战争分析

第八章：人工智能影响分析

第九章：按产品类型

  • 蘸液器
  • 试剂
  • 一次性用品
  • 其他产品

第十章：按测试类型分类

  • 尿液检测
  • 血液检测
  • 其他

第十一章：按终端用户分类

  • 医院
  • 诊断中心
  • 研究实验室和研究所
  • 其他

第十二章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第13章 ：竞争格局

  • 竞争格局
  • 市场份额分析
  • 合併和收购分析

第十四章：公司简介

  • F. Hoffmann-La Roche Ltd
    • 公司概述
    • 产品组合和描述
    • 财务概况
    • 主要发展情况
  • Nova Biomedical
  • Quest Diagnostics
  • 77 Elektronika Kft
  • ACON Laboratories, Inc.
  • Beckman Coulter
  • Abbott
  • bioMerieux SA
  • OPTI Medical
  • Siemens Healthineers.

第十五章 ：附录

简介目录
Product Code: CD5823

Market Overview

The Global Kidney Function Tests Market reached US$ 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 1.4 billion by 2030. The market is expected to exhibit a CAGR of 6.3% during the forecast period 2023-2030.

Kidney function tests identify kidney or renal function disorders and assist doctors in prescribing appropriate medicine. Dilution tests, clearance tests and other types of kidney function tests are available. Kidney diseases such as trouble urinating due to excess bodily fluids, edema in the hands or feet, and swollen face can be identified using a kidney function test.

The factors driving the growth of the market include FDA approvals and the launch of new products by the key players for kidney function tests. For instance, on July 12, 2022, Healthy.io, the global pioneer in integrating the smartphone camera into a medical device, announced that the Minuteful Kidney test has acquired 510(k) clearance from the US Food and Drug Administration (FDA) for home use.

Market Dynamics

Increasing the Prevalence of Kidney Diseases will Drive the Kidney Function Tests Market Growth

The global rise in the incidence and prevalence of chronic kidney disease is a major factor driving the growth of the global kidney function testing market. For instance, according to NIDDK 2021, Chronic kidney disease (CKD) affects more than one in every seven adults in the United States, totaling an estimated 37 million people.

The risk of CKD is even higher for Americans who have diabetes or high blood pressure, the two most frequent causes of kidney disease. Kidney disease affects nearly one-third of people with diabetes and one-fifth of people with high blood pressure.

Additionally, according to the Centers for Disease Control and Prevention's (CDC) Chronic Kidney Disease in the United States, 2021, CKD is slightly more prevalent in women (14%) than in men (12%), and it is more common in non-Hispanic Black adults (16%) than in non-Hispanic white adults (13%) or non-Hispanic Asian people (13%). Thus, the frequency of CKD will fuel market expansion.

High Diagnostic Process Costs are Expected to Hamper the Market Growth

The high cost of kidney function tests, as well as the low acceptance rate in emerging and developing nations, will stifle market expansion. The increased number of people with a clinical diagnosis of kidney disease as a result of the modified formula means that more people may receive recommendations for dose adjustments or contraindications for certain drugs that may interfere with kidney function or be poorly filtered by the kidneys.

COVID-19 Impact Analysis

The pandemic of COVID-19 has had a moderate impact on healthcare systems and the market. According to a study published in medRXiv in April 2020, COVID-19 urine incontinence was often observed in persons with a variety of infectious and harmful illnesses. Children aged 0 to 12 who have a little light type of COVID-19 have been found to have urinary tract COVID-19 exposure.

COVID-19 urinary tract infections were identified between the first and fifth days after the disease's onset. Kidney function markers are used to determine how well the kidneys function. Some signals are radioactive as well as non-radioactive. They demonstrate the kidneys' glomerular filtration rate as well as their concentrating and diluting capacities (tubular function). Many people would rather buy a kidney function test at a store than online.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global kidney function tests market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products and devices is anticipated to have little influence over the global kidney function tests market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global preeclampsia market positively. Artificial intelligence-powered decision support systems can help healthcare personnel make well-informed judgements about renal diagnosis and treatment options. These systems are capable of analyzing patient data, comparing it to current medical knowledge and making suggestions based on evidence-based guidelines. This assists doctors in selecting the best diagnostic tests, drugs or actions for particular patients.

Segment Analysis

The global kidney function tests market is segmented based on product type, test type end user and region.

The Dipstick Segment is Estimated to Hold the Majority of the Kidney Function Tests Market Share During the Forecast Period

The Dipstick product type holds about 47.3% of the total kidney function tests market in the forecast period. Dipstick tests provide rapid results, usually within a few minutes, allowing for immediate assessment of kidney health. They are easy to use and do not require extensive laboratory equipment or specialized training, making them accessible in various healthcare settings, including clinics, emergency rooms and home.

This aids in the diagnosis of a variety of renal and urinary issues, including chronic kidney disease, bladder infections and kidney stones. Furthermore, the increasing number of people and important companies' strategies in renal function testing promote some growth.

For instance, Sweden's Elypta AB raised USD 7.0 million in January 2020 for a urine cancer screening test. Therefore, a patient's urine can reveal a lot of information about their health, increasing the use of dipsticks. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America Holds a Dominant Position in the Global Kidney Function Tests Market

The North American region holds the second-largest share of the global kidney function tests market accounting for approximately 39.4% in the forecast period. Due to well-established healthcare infrastructure, widespread awareness of CKD and favorable reimbursement policies and government initiatives. Furthermore, the region's main manufacturers are focused on inventing innovative products.

For instance, Abbott HealthTab signed a non-assignable, pilot supplier distribution agreement with Abbott in November 2021 for i-STAT Alinity, a handheld blood chemistry analyzer. The partnership allows HealthTab to sell Abbott's POC i-STAT Alinity and associated creatinine tests in Canadian pharmacies, providing patients with important information regarding their kidney functioning.

Competitive Landscape

The major global players in the market include: F. Hoffmann-La Roche Ltd, Nova Biomedical, Quest Diagnostics, 77 Elektronika Kft, ACON Laboratories, Inc., Beckman Coulter, Abbott, bioMerieux SA, OPTI Medical, Siemens Healthineers. among others.

Why Purchase the Report?

  • To visualize the global kidney function tests market segmentation based on product type, test type, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of kidney function tests market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in Excel consisting of key products of all the major players.

The Global Kidney Function Tests Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 pages.

Target Audience 2023

  • Manufacturers / Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Test Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing product launches for kidney function tests
      • 4.1.1.2. Increasing the prevalence of kidney diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High diagnostic process costs growth
    • 4.1.3. Opportunity
      • 4.1.3.1. Kidney function tests help healthcare providers develop individualized treatment plans for patients
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Product Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.1.2. Market Attractiveness Index, By Product Type
  • 9.2. Dipsticks
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Reagents
  • 9.4. Disposables
  • 9.5. Others

10. By Test Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 10.1.2. Market Attractiveness Index, By Test Type
  • 10.2. Urine test
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Blood test
  • 10.4. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Diagnostic Centers
  • 11.4. Research laboratories and institutes
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.6.1. The U.S.
      • 12.2.6.2. Canada
      • 12.2.6.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.6.1. Germany
      • 12.3.6.2. The U.K.
      • 12.3.6.3. France
      • 12.3.6.4. Italy
      • 12.3.6.5. Spain
      • 12.3.6.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.6.1. Brazil
      • 12.4.6.2. Argentina
      • 12.4.6.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.6.1. China
      • 12.5.6.2. India
      • 12.5.6.3. Japan
      • 12.5.6.4. Australia
      • 12.5.6.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. F. Hoffmann-La Roche Ltd
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Nova Biomedical
  • 14.3. Quest Diagnostics
  • 14.4. 77 Elektronika Kft
  • 14.5. ACON Laboratories, Inc.
  • 14.6. Beckman Coulter
  • 14.7. Abbott
  • 14.8. bioMerieux SA
  • 14.9. OPTI Medical
  • 14.10. Siemens Healthineers.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us